search
Back to results

Spine Fusion Instrumented With BMP-2 vs Uninstrumented With Infuse BMP-2 Alone

Primary Purpose

Degenerative Lumbar Disc Disease, Spondylolisthesis, Spinal Stenosis

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Device used in surgery with or without instrumentation
Sponsored by
Nova Scotia Health Authority
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Degenerative Lumbar Disc Disease focused on measuring Lumbar degenerative disease, spinal stenosis, spondylolisthesis, non instrumented surgery, instrumented surgery, BMP-2

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria:

  • Patient not currently participating in a drug or medical clinical trial.
  • Patient signed informed consent.
  • Patient is willing to be available for each examination scheduled over the study duration.
  • Patient has clinical and radiologic history of degenerative disc disease or spondylolisthesis (no greater than grade 1 utilizing Meyerding's classification (Meyerding HW, 1932)); spinal stenosis for which conservative treatment has failed and lumbar spinal fusion is indicated.
  • Eligible for non-instrumented or instrumented surgical procedure
  • Has one or two levels (contiguous) involvement from L1-S1 requiring fusion
  • Has preoperative Oswestry score greater than 30
  • Has not responded to non-operative treatment for a period of 6 months (bed rest, physical therapy, medication, manipulations, spinal injections, other).
  • Is at least 20 years of age inclusive at the day of surgery
  • If female of childbearing potential, patient is non-pregnant, non-nursing, and agrees to use adequate contraception for one year following surgery.

Exclusion Criteria:

  • Patient has a systemic infection.
  • Patient has had more than one previous non-fusion spinal surgery at the involved level.
  • Patient requires fusion at more than 2 levels.
  • Patient has pseudoarthroses from a previous fusion attempt.
  • Patient has highly communicable diseases, inflammatory or autoimmune disease (e.g.osteomyelitis, crohn's, rheumatoid arthritis, systemic lupus, gout, HIV/AIDS, active tuberculosis, venereal disease, active hepatitis). A note to file written by the investigator will permit a patient into the study who experiences a mild case which will not affect the outcome of the study.
  • Has been previously diagnosed with osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
  • Patient has a significant medical history that, in the Investigator's opinion would not make them a good study candidate.
  • Patient requires interbody cage fusion or non-pedicle screw instrumentation.
  • Pregnancy.
  • Has presence of active malignancy (except basal cell carcinoma of the skin)
  • Has a history of severe allergy (anaphylaxis)
  • Is grossly obese, i.e. weight over 40% over ideal for their height and age.
  • Has a fever (temperature over 101 F oral)
  • Has an allergy to the BMP-2
  • Has allergy to bovine products
  • Has an allergy to collagen implants
  • Is mentally incompetent(if questionable, obtain psychiatric consult)
  • Is a prisoner, a transient or have been treated in an inpatient substance abuse program for alcohol and/or drug abuse within six months prior to proposed study enrollment.
  • Has received drugs which may interfere with bone metabolism within two weeks prior to the planned surgery
  • Has a diagnosis, which requires postoperative medication that interferes with fusion, such as steroids.
  • Has history of endocrine or metabolic disorder known to affect osteogenesis (e.g. Paget's disease, renal osteodystrophy, Ehlers-Danios syndrome or osteogenesis imperfecta)

Sites / Locations

  • Capital Health Health Authority, QEII Health Sciences Centre, Halifax Infirmary site,

Arms of the Study

Arm 1

Arm Type

Active Comparator

Arm Label

Device

Arm Description

Device used in surgery with or without instrumentation

Outcomes

Primary Outcome Measures

To evaluate bone fusion;
Radiology tests; CT spine 24mon.
Clinical neurological evaluations; patient questionnaires

Secondary Outcome Measures

Hospital and surgical data
Adverse events

Full Information

First Posted
November 28, 2006
Last Updated
February 13, 2013
Sponsor
Nova Scotia Health Authority
search

1. Study Identification

Unique Protocol Identification Number
NCT00405600
Brief Title
Spine Fusion Instrumented With BMP-2 vs Uninstrumented With Infuse BMP-2 Alone
Official Title
A Prospective Randomized Clinical Investigation of Posterolateral Lumbosacral Spinal Fusions With BMP-2 and Titanium Pedicle Screw Instrumentation Versus BMP-2 Alone.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2013
Overall Recruitment Status
Completed
Study Start Date
November 2006 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
December 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nova Scotia Health Authority

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of spinal fusion is to relieve pain and/or increase stability in painful or unstable spine joints. A patient may or may not receive rods and screws with the use of bone graft materials to facilitate bone growth and a fusion thus preventing movement of the bones of the spine. In this research study, bone graft substitute material called Bone Morphogenetic Protein-2 known as BMP-2 Infuse will be used. No hip bone will be used. The surgical procedure will consist of BMP-2 Infuse with or without the use of rods and screws.
Detailed Description
In this study we will be using BMP-2 Infuse instead of the iliac crest bone graft for the spinal fusion. The BMP-2 Infuse has been researched in the only completed clinical trial for spinal fusions. It has demonstrated equivalence to the iliac crest bone graft with regard to both fusion rate and clinical outcome. Currently, the acceptable standard of care for spinal fusion surgery requires instrumented or non-instrumented procedure with the use of bone graft materials, to facilitate bone growth, and a fusion, thus eliminating movement between the inciting vertebrae. In this study, the surgical procedure will be BMP-2 Infuse with instrumentation or BMP-2 Infuse alone.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Degenerative Lumbar Disc Disease, Spondylolisthesis, Spinal Stenosis
Keywords
Lumbar degenerative disease, spinal stenosis, spondylolisthesis, non instrumented surgery, instrumented surgery, BMP-2

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Device
Arm Type
Active Comparator
Arm Description
Device used in surgery with or without instrumentation
Intervention Type
Procedure
Intervention Name(s)
Device used in surgery with or without instrumentation
Intervention Description
Infuse Bone Graft BMP-2, Large Kit will be used in all surgeries. Spine surgeries will be either instrumented or uninstrumented.
Primary Outcome Measure Information:
Title
To evaluate bone fusion;
Time Frame
3mon., 6mon., 12mon., 24mon
Title
Radiology tests; CT spine 24mon.
Time Frame
3mon., 6mon., 12mon., 24mon
Title
Clinical neurological evaluations; patient questionnaires
Time Frame
3mon., 6mon., 12mon., 24mon
Secondary Outcome Measure Information:
Title
Hospital and surgical data
Time Frame
hospitalization;
Title
Adverse events
Time Frame
hospitalization, clinic visits, unscheduled visits

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: Patient not currently participating in a drug or medical clinical trial. Patient signed informed consent. Patient is willing to be available for each examination scheduled over the study duration. Patient has clinical and radiologic history of degenerative disc disease or spondylolisthesis (no greater than grade 1 utilizing Meyerding's classification (Meyerding HW, 1932)); spinal stenosis for which conservative treatment has failed and lumbar spinal fusion is indicated. Eligible for non-instrumented or instrumented surgical procedure Has one or two levels (contiguous) involvement from L1-S1 requiring fusion Has preoperative Oswestry score greater than 30 Has not responded to non-operative treatment for a period of 6 months (bed rest, physical therapy, medication, manipulations, spinal injections, other). Is at least 20 years of age inclusive at the day of surgery If female of childbearing potential, patient is non-pregnant, non-nursing, and agrees to use adequate contraception for one year following surgery. Exclusion Criteria: Patient has a systemic infection. Patient has had more than one previous non-fusion spinal surgery at the involved level. Patient requires fusion at more than 2 levels. Patient has pseudoarthroses from a previous fusion attempt. Patient has highly communicable diseases, inflammatory or autoimmune disease (e.g.osteomyelitis, crohn's, rheumatoid arthritis, systemic lupus, gout, HIV/AIDS, active tuberculosis, venereal disease, active hepatitis). A note to file written by the investigator will permit a patient into the study who experiences a mild case which will not affect the outcome of the study. Has been previously diagnosed with osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated Patient has a significant medical history that, in the Investigator's opinion would not make them a good study candidate. Patient requires interbody cage fusion or non-pedicle screw instrumentation. Pregnancy. Has presence of active malignancy (except basal cell carcinoma of the skin) Has a history of severe allergy (anaphylaxis) Is grossly obese, i.e. weight over 40% over ideal for their height and age. Has a fever (temperature over 101 F oral) Has an allergy to the BMP-2 Has allergy to bovine products Has an allergy to collagen implants Is mentally incompetent(if questionable, obtain psychiatric consult) Is a prisoner, a transient or have been treated in an inpatient substance abuse program for alcohol and/or drug abuse within six months prior to proposed study enrollment. Has received drugs which may interfere with bone metabolism within two weeks prior to the planned surgery Has a diagnosis, which requires postoperative medication that interferes with fusion, such as steroids. Has history of endocrine or metabolic disorder known to affect osteogenesis (e.g. Paget's disease, renal osteodystrophy, Ehlers-Danios syndrome or osteogenesis imperfecta)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr. David Alexander, M.D.
Organizational Affiliation
Capital Health District Authority, Centre for Clinical Research, Queen Elizabeth II, Health Sciences Centre, 1278 Tower Rd.,Halifax, Nova Scotia, B3H-9Z9, Canada
Official's Role
Principal Investigator
Facility Information:
Facility Name
Capital Health Health Authority, QEII Health Sciences Centre, Halifax Infirmary site,
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H-3A7
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Spine Fusion Instrumented With BMP-2 vs Uninstrumented With Infuse BMP-2 Alone

We'll reach out to this number within 24 hrs